Adaptive Biotechnologies Corp (NAS:ADPT)
$ 3.32 -0.14 (-4.06%) Market Cap: 489.26 Mil Enterprise Value: 296.04 Mil PE Ratio: 0 PB Ratio: 1.77 GF Score: 72/100

Q1 2022 Adaptive Biotechnologies Corp Earnings Call Transcript

May 04, 2022 / 08:30PM GMT
Release Date Price: $9.25 (+3.35%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Adaptive Biotechnologies' First Quarter 2022 Financial Results Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Karina Calzadilla, Head of Investor Relations. Please go ahead, ma'am.

Karina Calzadilla
Adaptive Biotechnologies Corporation - VP of IR

Thank you, Alexandre, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies' First Quarter 2022 Earnings Conference Call. Earlier today, we issued a press release reporting Adaptive's financial results for the first quarter of 2022. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call, and we'll be referencing to a slide presentation that has been posted to the Investors section in our corporate website.

During the call, management will make projections and other forward-looking statements within the meaning of federal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot